EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The chemo therapy of rodent malaria part 28 the development of resistance to mefloquine wr 142490



The chemo therapy of rodent malaria part 28 the development of resistance to mefloquine wr 142490



Annals of Tropical Medicine and Parasitology 71(4): 419-428



Using a relapse technique resistance of the Plasmodium berghei N strain to mefloquine can be developed slowly, but the progress is more rapid in the chloroquine-resistant NS line. Mefloquine resistance in all these lines is very unstable in the absence of drug selection pressure. Resistance develops also when the N strain is submitted to slowly increasing mefloquine dosage in consecutive passages, the resulting parasites having a similar morphology at light microscopic level to chloroquine-resistant P. berghei RC line parasites. Like the latter they occupy polychromatophilic red blood cells almost exclusively. When the parasites are exposed to mixtures of mefloquine with pyrimethamine, sulfaphenazole or primaquine, resistance to each component of the mixtures develops more slowly than to the individual components used alone. It is strongly recommended that mefloquine should be deployed only for the prevention or treatment of malaria in man caused by chloroquine-resistant P. falciparum. While it is appreciated that data based on rodent malaria models may not necessarily predict the situation in human malaria, the authors suggest that, for large scale use, mefloquine should not be employed until a 2nd antimalarial has been identified that will minimize the risk of parasites becoming resistant to this potentially valuable new compound.

(PDF emailed within 1 workday: $29.90)

Accession: 006614079

Download citation: RISBibTeXText



Related references

The chemo therapy of rodent malaria part 27 studies on mefloquine wr 142490. Annals of Tropical Medicine and Parasitology 71(4): 407-418, 1977

The chemo therapy of rodent malaria part 17 dynamics of drug resistance part 3 influence of drug combinations on the development of resistance to chloroquine in plasmodium berghei. Annals Of Tropical Medicine & Parasitology: 143-154, 1973

The chemo therapy of rodent malaria part 16 primary resistance to mepacrine in the n 67 strain of plasmodium berghei type parasite. Annals of Tropical Medicine & Parasitology 67(2): 133-141, 1973

The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490). Annals of Tropical Medicine and Parasitology 71(4): 419-427, 1977

The chemo therapy of rodent malaria part 14 the action of some sulfonamides alone or with folic reductase inhibitors against malaria vectors and parasites part 4 the response of normal and drug resistant strains of plasmodium berghei. Annals of Tropical Medicine & Parasitology 65(2): 123-129, 1971

The chemo therapy of rodent malaria part 26 the potential value of wr 122455 a 9 phenanthrenemethanol against drug resistant malaria parasites. Annals of Tropical Medicine and Parasitology 70(3): 271-281, 1976

The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium. Annals of Tropical Medicine and Parasitology 85(1): 5-10, 1991

Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Bulletin of the World Health Organization 51(4): 375-377, 1974

Studies on the chemo therapy of rodent malaria and drug resistance. U S Government Research & Development Reports 70(18): 50, 1970

The chemo therapy of rodent malaria part 29 dna relationships within the subgenus plasmodium. Annals of Tropical Medicine and Parasitology 72(1): 13-22, 1978

The chemo therapy of rodent malaria part 23 causal prophylaxis part 2 practical experience with plasmodium yoelii nigeriensis in drug screening. Annals of Tropical Medicine and Parasitology 69(3): 311-328, 1975

The chemo therapy of rodent malaria part 30 the enigmas of the ns lines of plasmodium berghei. Annals of Tropical Medicine and Parasitology 72(1): 23-36, 1978

The chemo therapy of rodent malaria part 18 the action of some sulfonamides alone or with folic reductase inhibitors against malaria vectors and parasites part 5 the blood schizontocidal action of some newer sulfonamides. Annals of Tropical Medicine & Parasitology 67(2): 155-167, 1973

The chemo therapy of rodent malaria part 8 the action of some sulfonamides alone or with folic reductase inhibitors against malaria vectors and parasites 3 the action of sulformethoxine and pyrimethamine on the sporogonic stages. Annals of Tropical Medicine & Parasitology 63(4): 449-454, 1969

The chemo therapy of rodent malaria part 20 autophagic vacuole formation in plasmodium berghei in vitro. Annals of Tropical Medicine & Parasitology 68(3): 265-281, 1974